Amoy Diagnostics released its 2026 interim report, with net profit attributable to the parent company of 166 million yuan, a decrease of 12.12% compared with the same period last year. Total operating revenue was 559 million yuan, down 3.45% year-on-year; net cash inflow from operating activities was 195 million yuan. The latest gross margin was 83.41%, a decrease of 0.59 percentage points from the same period last year; diluted earnings per share was 0.42 yuan, down 12.50% year-on-year.
Amoy Diagnostics Co LtdNet profit down 12.12% and revenue down 3.45% in interim report.